Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer- a Cost Minimization Analysis in Twelve European Countries
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1112
https://www.valueinhealthjournal.com/article/S1098-3015(15)03188-5/fulltext
Title :
Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer- a Cost Minimization Analysis in Twelve European Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03188-5&doi=10.1016/j.jval.2015.09.1112
First page :
A446
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
610